Published in Cardiovasc Res on June 01, 2004
Transforming growth factor beta signaling in adult cardiovascular diseases and repair. Cell Tissue Res (2011) 1.10
Central role of Gq in the hypertrophic signal transduction of angiotensin II in vascular smooth muscle cells. Endocrinology (2008) 1.00
Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure. Integr Blood Press Control (2013) 0.98
Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD. Transl Res (2007) 0.98
Albumin endocytosis in proximal tubule cells is modulated by angiotensin II through an AT2 receptor-mediated protein kinase B activation. Proc Natl Acad Sci U S A (2005) 0.97
Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2. Exp Diabetes Res (2011) 0.94
Novel role of protein kinase C-delta Tyr 311 phosphorylation in vascular smooth muscle cell hypertrophy by angiotensin II. Hypertension (2008) 0.93
Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1-7). Biochem J (2006) 0.90
Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J Cereb Blood Flow Metab (2011) 0.88
Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo. Br J Pharmacol (2015) 0.86
Roles of Brain Angiotensin II in Cognitive Function and Dementia. Int J Hypertens (2012) 0.84
Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury. Neurotherapeutics (2014) 0.80
Bradykinin does not induce gap formation between human endothelial cells. Pflugers Arch (2007) 0.80
Effects of coronary ischemia-reperfusion in a rat model of early overnutrition. Role of angiotensin receptors. PLoS One (2013) 0.79
Deficiency of intrarenal angiotensin II type 2 receptor impairs paired homeo box-2 and N-myc expression during nephrogenesis. Pediatr Nephrol (2008) 0.77
Effect of unilateral ureteral obstruction and anti-angiotensin II treatment on renal tubule and interstitial cell apoptosis in rats. Croat Med J (2008) 0.75
MAPK and angiotensin II receptor in kidney of newborn rats from losartan-treated dams. Pediatr Nephrol (2008) 0.75
The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke (2003) 4.63
Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol (2004) 3.18
Organotypic slice culture from human adult ventricular myocardium. Cardiovasc Res (2011) 1.78
Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*. J Hypertens (2006) 1.74
Differential expression of AT1 receptors in the pituitary and adrenal gland of SHR and WKY. Hypertension (2003) 1.61
Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects. J Hypertens (2002) 1.54
Brain nitric oxide synthase activity in spontaneously hypertensive rats during the development of hypertension. J Hypertens (2003) 1.53
Comparison of the vascular and antiadrenergic activities of four angiotensin II type 1 antagonists in the pithed rat. J Hypertens (2002) 1.40
Remote preconditioning protects the heart by activating myocardial PKCepsilon-isoform. Cardiovasc Res (2002) 1.31
Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase. J Cardiovasc Pharmacol (2003) 1.19
Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway. J Cardiovasc Pharmacol (2004) 1.17
Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR. J Hypertens (2004) 1.17
Hypoxia rapidly activates HIF-3alpha mRNA expression. FASEB J (2003) 1.09
Identification and functional analysis of novel THAP1 mutations. Eur J Hum Genet (2011) 1.08
Angiotensin II induces catecholamine release by direct ganglionic excitation. Hypertension (2002) 1.03
Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact? Int J Biochem Cell Biol (2003) 1.01
Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways. Cardiovasc Res (2007) 0.98
Biochemical characterization of kappaM-RIIIJ, a Kv1.2 channel blocker: evaluation of cardioprotective effects of kappaM-conotoxins. J Biol Chem (2010) 0.96
Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats. Endocrinology (2006) 0.94
Non-hypoxic induction of HIF-3alpha by 2-deoxy-D-glucose and insulin. Biochem Biophys Res Commun (2006) 0.94
Bradykinin potentiation by ACE inhibitors: a matter of metabolism. Br J Pharmacol (2002) 0.91
Calcitonin gene related peptide mediates cardioprotection by remote preconditioning. Regul Pept (2005) 0.90
Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus. Peptides (2002) 0.90
Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals. Free Radic Biol Med (2005) 0.90
Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene. FASEB J (2004) 0.88
Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation. J Clin Invest (2014) 0.87
Role of neuronal KATP channels and extraneuronal monoamine transporter on norepinephrine overflow in a model of myocardial low flow ischemia. J Pharmacol Exp Ther (2004) 0.87
Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors? J Hypertens (2002) 0.86
Angiotensin II stimulates the reactivity of the pituitary-adrenal axis in leptin-resistant Zucker rats, thereby influencing the glucose utilization. Am J Physiol Endocrinol Metab (2007) 0.85
Overfeeding-induced obesity in spontaneously hypertensive rats: an animal model of the human metabolic syndrome. Ann Nutr Metab (2010) 0.85
Organ-specific extravasation of albumin-bound Evans blue during nonresuscitated hemorrhagic shock in rats. Shock (2003) 0.85
Angiotensin I-converting enzyme inhibition increases cardiac catecholamine content and reduces monoamine oxidase activity via an angiotensin type 1 receptor-mediated mechanism. J Pharmacol Exp Ther (2002) 0.84
Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction. Eur J Pharmacol (2006) 0.84
Truncating mutations in THAP1 define the nuclear localization signal. Mov Disord (2011) 0.84
Gene expression of mineralocorticoid and glucocorticoid receptors in the limbic system is related to type-2 like diabetes in leptin-resistant rats. Brain Res (2007) 0.84
Neutral endopeptidase is activated in cardiomyocytes in human aortic valve stenosis and heart failure. Circulation (2002) 0.83
Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction. Br J Pharmacol (2002) 0.83
Influence of captopril on symptomatic and hormonal responses to hypoglycaemia in humans. Br J Clin Pharmacol (2003) 0.83
Cardiac kinin level in experimental diabetes mellitus: role of kininases. Am J Physiol Heart Circ Physiol (2003) 0.82
Gonadal steroids differentially regulate the messenger ribonucleic acid expression of pituitary orexin type 1 receptors and adrenal orexin type 2 receptors. Endocrinology (2003) 0.81
Radioprotective effect of lidocaine on function and ultrastructure of salivary glands receiving fractionated radiation. Int J Radiat Oncol Biol Phys (2012) 0.81
Long-term results of autologous submandibular gland transfer for the surgical treatment of severe keratoconjunctivitis sicca. J Craniomaxillofac Surg (2008) 0.81
Pioglitazone prevents capillary rarefaction in streptozotocin-diabetic rats independently of glucose control and vascular endothelial growth factor expression. J Vasc Res (2012) 0.80
Reduction of vascular noradrenaline sensitivity by AT1 antagonists depends on functional sympathetic innervation. Hypertension (2004) 0.80
Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells. Am J Physiol Regul Integr Comp Physiol (2009) 0.80
Inhibition of the renin-angiotensin system and the prevention of stroke. Am J Cardiovasc Drugs (2007) 0.79
Inhibition of nonexocytotic norepinephrine release by desipramine reduces myocardial infarction size. Can J Physiol Pharmacol (2006) 0.79
Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model. Biol Chem (2008) 0.79
Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation? Basic Res Cardiol (2002) 0.79
Peripheral sympatholytic actions of four AT1 antagonists: are they relevant for long-term antihypertensive efficacy? J Hypertens (2005) 0.78
Stress sensitivity is increased in transgenic rats with low brain angiotensinogen. J Endocrinol (2009) 0.77
Kinin B2 receptor localization and expression in the hypothalamo-pituitary-adrenal axis of spontaneously hypertensive rats. Int Immunopharmacol (2003) 0.77
Angiotensin I-converting enzyme-dependent and neutral endopeptidase-dependent generation and degradation of angiotensin II contrarily modulate noradrenaline release: implications for vasopeptidase-inhibitor therapy? J Hypertens (2005) 0.77
Norepinephrine release is reduced by I(1)-receptors in addition to alpha(2)-adrenoceptors. Ann N Y Acad Sci (2003) 0.76
AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats. FASEB J (2002) 0.76
Modification of noradrenaline release in pithed spontaneously hypertensive rats by I1-binding sites in addition to alpha2-adrenoceptors. J Pharmacol Exp Ther (2003) 0.76
Impairment of presynaptic alpha2-adrenoceptor-regulated norepinephrine overflow in failing hearts from Zucker diabetic fatty rats. J Cardiovasc Pharmacol (2006) 0.76
Expression of nitric oxide synthase isoforms in hypothalamo-pituitary-adrenal axis during the development of spontaneous hypertension in rats. Brain Res Mol Brain Res (2005) 0.76
Adrenal expression of orexin receptor subtypes is differentially regulated in experimental streptozotocin induced type-1 diabetes. Peptides (2006) 0.75
Inhibition of kinin breakdown prolongs retention and action of bradykinin in a myocardial B2 receptor compartment. Br J Pharmacol (2003) 0.75
Radioprotective effect of lidocaine on neurotransmitter agonist-induced secretion in irradiated salivary glands. PLoS One (2013) 0.75
Effect of ACE-inhibitor ramiprilat and AT1-receptor antagonist candesartan on cardiac norepinephrine release: comparison between ischemic and nonischemic conditions. J Cardiovasc Pharmacol (2002) 0.75
Calcitonin gene-related peptide does not interact with sympathetic activity in myocardial ischemia. Regul Pept (2005) 0.75
Adenylyl cyclase-dependent inhibition of myocardial norepinephrine release by presynaptic adenosine A1-receptors. J Cardiovasc Pharmacol (2005) 0.75
Acute hypothalamo-pituitary-adrenal axis response to LPS-induced endotoxemia: expression pattern of kinin type B1 and B2 receptors. Biol Chem (2016) 0.75
Expression of kinin receptor mRNA in the HPA axis of type 1 and type 2 diabetic rats. Int Immunopharmacol (2004) 0.75
Upregulation of the high mobility group AT-hook 2 gene in acute aortic dissection is potentially associated with endothelial-mesenchymal transition. Histol Histopathol (2011) 0.75
Prophylactic gamma radiation of unaffected vein grafts failed to prevent vein graft disease in a chronic hypercholesterolemic porcine model. Eur J Cardiothorac Surg (2003) 0.75